Company
Wittycell is developing novel adjuvant products for therapeutic and prophylactic Vaccines based on the Company’s proprietary technology.
Since its foundation, Wittycell S.A.S. has developed a new family of vaccine adjuvants , which aim to satisfy...
Press Release
January 04, 2012
Press #17 : Wittycell clinical trial
Wittycell is proud to announce the initiation of our first Phase I/IIa clinical trial :
a Phase I double-blind trial to......
Download Area
Designed by Haute Mer